tert-Butyl 7-nitro-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 5g

5-Chloro-3-fluorophenylacetic acid, 95.0%, 100g

2-(2,6-Dimethoxybenzoyl)-5-methylpyridine, 97.0%, 1g

Methyl 3,5-Di-tert-butylsalicylate, 50g

Differential Reinforced Clostridial Medium

2-(3,5-Difluorophenyl)-5,5-dimethyl-1,3,2-dioxaborinane, 95.0%, 1g

2-Fluoro-6-[(1-methylpiperidin-4-yl)methoxy]aniline, 95.0%, 1g

3-Aminopiperidine-2,6-dione hydrochloride, 97.0%, 100g

Di-potassium hydrogen phosphate, min. 98%, Ph.Eur., anhydrous, 1 kg, plastic packaging.

4-Bromo-5-fluoro-2-methylbenzaldehyde, 95.0%, 25g

Oxaloacetic acid, min. 98%, for biochemistry, 5 g, glass packaging

(6-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid, 95.0%, 1g

2-Bromo-N-hexadecylacetamide, 95.0%, 5g